Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors
Clinical trial NCT04190628 · TERMINATED
Trial details
- NCT number
- NCT04190628
- Sponsor
- ABM Therapeutics Corporation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-16
- Primary completion
- 2024-04-05
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.